MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-16-2023
Trean Insurance Group P/B Ratio 2011-2026 | TIG
Annual P/B Ratio Trean Insurance Group
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.985 | 1.08 | 1.4 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.4 | 0.985 | 1.15 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
1.66 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
0.036 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
7.43 | - | 0.74 % | $ 768 M |  Israel |
 |
AbbVie
ABBV
|
2.98 | $ 201.55 | - | $ 357 B | USA |
 |
Anika Therapeutics
ANIK
|
1.38 | $ 14.77 | - | $ 216 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.57 | - | $ 418 M | Britain |
 |
BioNTech SE
BNTX
|
1.15 | $ 94.13 | - | $ 22.8 B | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Compugen Ltd.
CGEN
|
2.26 | $ 2.9 | - | $ 271 M | Israel |
 |
Checkmate Pharmaceuticals
CMPI
|
0.759 | - | - | $ 231 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
0.0227 | $ 0.77 | - | $ 35.2 M | Israel |
 |
ACADIA Pharmaceuticals
ACAD
|
4.36 | $ 22.4 | - | $ 3.71 B | USA |
 |
Esperion Therapeutics
ESPR
|
-1.86 | $ 3.14 | - | $ 653 M | USA |
 |
Exelixis
EXEL
|
5.42 | $ 48.16 | - | $ 13.1 B | USA |
 |
Genmab A/S
GMAB
|
0.052 | $ 26.43 | - | $ 1.71 B |  Danmark |
 |
Fortress Biotech
FBIO
|
1.25 | $ 2.39 | - | $ 66.7 M | USA |
|
Forte Biosciences
FBRX
|
5.5 | $ 24.02 | - | $ 311 M | USA |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 3.51 | -0.57 % | $ 5.78 M | Israel |
 |
Aeterna Zentaris
AEZS
|
1.12 | - | 5.93 % | $ 314 M | Canada |
 |
Gilead Sciences
GILD
|
3.11 | $ 131.33 | - | $ 163 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
Genprex
GNPX
|
0.207 | $ 0.87 | - | $ 811 K | USA |
 |
Grifols, S.A.
GRFS
|
0.525 | $ 8.1 | - | $ 5.51 B |  Spain |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 21.17 | - | $ 2.69 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
0.904 | $ 225.79 | - | $ 13.8 B |  Irlanda |
 |
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | USA |
 |
Applied Therapeutics
APLT
|
-31.5 | - | - | $ 8.42 M | USA |